白细胞介素类生物制剂治疗类风湿关节炎安全性的Meta分析(5)
[12]GENOVESE MC，MCKAY JD，NASONOV EL，et al.Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs：the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study[J].Arthritis Rheum ......
您现在查看是摘要页，全文长 2855 字符。